2BBBullish & Bearish
Alcon AG (ALC) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 53 out of 100.
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company.
Alcon AG’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 49 | Moderate |
| Momentum | 67 | Improving |
| Financial strength | 74 | Strong |
| Quality | 93 | Very Strong |
| Risk | 47 | Moderate |
| CEO | David J. Endicott |
| Headquarters | Geneva, Geneva, Switzerland |
| Founded | 1945 |
| Employees | 25K |
| 52-week range | $61.84 – $87.64 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | 0.9585 | — | $2.88B |
| 2026-11-11 | — | 0.8865 | — | $2.77B |
| 2026-08-10 | — | 0.7601 | — | $2.80B |